Sun Pharma, eClerx, IEX, Anant Raj, REC, Aether Industries, L&T, Enviro Infra, GR Infraprojects, Adani Enterprises in focus on 25 July Karur Vysya Bank announces its first bonus issue in 7 years: What ...

Patents are the principal form of IP protection for vaccines and medicines. They grant pharmaceutical companies the right to ...

The broker cited stretched valuations and slower-than-expected traction in speciality drugs. It flagged concerns around ...

Indian benchmark indices Sensex and Nifty ended lower on Tuesday, after the United States issued a draft notice to impose ...

BoFA values the stock at 32 times FY27 earnings against its 10-year average of 25.5 times, reflecting its transition to ...

At the close, the BSE Sensex dropped 849.37 points, or 1.04%, to 80,786.54, while the NSE Nifty 50 slipped 255.7 points, or 1 ...

Indian stock market indices Sensex and Nifty plunged significantly due to concerns over US tariffs and foreign fund outflows, ...

Sun Pharmaceutical shares dropped by 2.8% after Bank of America downgraded the stock due to concerns over premium valuations and slower speciality execution.

Bank of America downgraded Sun Pharma stock to ‘underperform’ from ‘neutral’, citing risks to premium valuations and slower ...

Indian pharmaceutical stocks slipped sharply on Tuesday after US President Donald Trump vowed to slash drug prices ...

In Nifty Realty, Godrej Properties, Lodha, and DLF led losses by nearly 2% each. Nifty Pharma was trading at 22,082.55, lower ...